Perrigo's Rx Business Looks Ready To Sell, Says Hedge Fund Investor

Starboard Value states says Perrigo "severely mismanaged" its entry into branded consumer health through the acquisition of a German firm and showed "misguided confidence" in encouraging shareholders to reject Mylan's tender.